Compugen (CGEN) Enterprise Value (2009 - 2026)
Compugen (CGEN) posted quarterly Enterprise Value of -$91.8 million for Q1 2026, down 29.13% year-over-year from -$129.5 million in Q1 2025, and up 32.71% on a QoQ basis from -$136.4 million in Q4 2025.
Compugen (CGEN) Enterprise Value (2009 - 2026) Analysis & Trends
Compugen has reported Enterprise Value for 18 years, with the latest figure at -$91.8 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$91.8 million, down 29.13% year-over-year; the trailing twelve-month figure through Mar 2026 was -$91.8 million (down 29.13% YoY), and the FY2025 annual result was -$136.4 million, down 71.25% from the prior year.
- Enterprise Value advanced to -$91.8 million in Q1 2026, from -$136.4 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$38.9 million in Q4 2023 and troughed at -$136.4 million in Q4 2025.
- A 5-year average of -$77.0 million and a median of -$74.3 million in 2023 frame the typical range for Enterprise Value.
- The widest annual swing landed in 2023, when Enterprise Value jumped 53.28%; it then plunged 104.47% in 2024.
- A 5-year view of Enterprise Value shows it stood at -$83.3 million in 2022, then jumped by 53.28% to -$38.9 million in 2023, then tumbled by 104.47% to -$79.6 million in 2024, then sank by 71.25% to -$136.4 million in 2025, then jumped by 32.71% to -$91.8 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$91.8 million in Q1 2026, -$136.4 million in Q4 2025, and -$59.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Compugen | 227.88 Mn | 136.13 Mn | 352,000.00 | -91.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -91.75 Mn |
| Dec 31, 2025 | -136.36 Mn |
| Sep 30, 2025 | -59.36 Mn |
| Jun 30, 2025 | -65.00 Mn |
| Mar 31, 2025 | -71.06 Mn |
| Dec 31, 2024 | -79.63 Mn |
| Sep 30, 2024 | -79.57 Mn |
| Jun 30, 2024 | -59.32 Mn |
| Mar 31, 2024 | -69.05 Mn |
| Dec 31, 2023 | -38.94 Mn |
| Sep 30, 2023 | -47.78 Mn |
| Jun 30, 2023 | -61.98 Mn |
| Mar 31, 2023 | -74.32 Mn |
| Dec 31, 2022 | -83.35 Mn |
| Sep 30, 2022 | -88.21 Mn |
| Jun 30, 2022 | -97.29 Mn |
| Mar 31, 2022 | -106.82 Mn |
| Dec 31, 2021 | -117.05 Mn |
| Sep 30, 2021 | -102.25 Mn |
| Jun 30, 2021 | -111.09 Mn |